UK-based SIRAKOSS has received 510(k) clearance from the FDA for a new synthetic bone graft substitute, Osteo3 ZP Putty.

The nanotechnology-derived product is designed to fill gaps and promote rapid bone regeneration following spinal and bone grafting procedures.

The synthetic technology was developed with government funding at the University of Aberdeen, Scotland.